1. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
    Pía Loren et al, 2022, Frontiers in Pharmacology CrossRef
  2. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
    Maria Konoshenko et al, 2022, International Journal of Molecular Sciences CrossRef

  3. MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway


    Zhilai Lin et al, 2020, OncoTargets and Therapy CrossRef
  4. The role of mutations in NF1 gene in sporadic carcinogenesis
    R. N. Mustafin, 2021, Advances in Molecular Oncology CrossRef
  5. Prospects for the treatment of neurofibromatosis type 1: A review
    Rustam N. Mustafin, 2022, Journal of Modern Oncology CrossRef

  6. Knockdown of miR-183 Enhances the Cisplatin-Induced Apoptosis in Esophageal Cancer Through Increase of FOXO1 Expression


    Hao Chen et al, 2020, OncoTargets and Therapy CrossRef